CAPTN-3

Business news, market intelligence, and global industry analysis.

The Latest

What the latest UTOPIA trial data reveal about UGN-103’s competitive position in LG-IR-NMIBC

Delivery Hero (DHER) stock up 4% to €29.5 as Aspex forces CEO exit and Korea sale opens

What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC

Hanwha Aerospace targets NATO demand with Romania unmanned systems push at BSDA 2026

How Purple Biotech’s CAPTN-3 platform achieved a tri-specific antibody manufacturing milestone with IM1240

Find out how Purple Biotech’s manufacturing milestone for IM1240 is validating the CAPTN-3 platform and transforming tri-specific antibody development.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

October 29, 2025